These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8195037

  • 1. Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation.
    Doherty N, Hancock SL, Kaye S, Coleman CN, Shulman L, Marquez C, Mariscal C, Rampling R, Senan S, Roemeling RV.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):379-82. PubMed ID: 8195037
    [Abstract] [Full Text] [Related]

  • 2. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors.
    Shulman LN, Buswell L, Riese N, Doherty N, Loeffler JS, von Roemeling RW, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):349-53. PubMed ID: 10760430
    [Abstract] [Full Text] [Related]

  • 3. Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
    Senan S, Rampling R, Graham MA, Wilson P, Robin H, Eckardt N, Lawson N, McDonald A, von Roemeling R, Workman P, Kaye SB.
    Clin Cancer Res; 1997 Jan 01; 3(1):31-8. PubMed ID: 9815534
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tirapazamine-cisplatin: the synergy.
    Gatzemeier U, Rodriguez G, Treat J, Miller V, von Roemeling R, Viallet J, Rey A.
    Br J Cancer; 1998 Jun 01; 77 Suppl 4(Suppl 4):15-7. PubMed ID: 9647615
    [Abstract] [Full Text] [Related]

  • 7. Phase I trial of i.v. administered tirapazamine plus cyclophosphamide.
    Hoff PM, Saad ED, Ravandi-Kashani F, Czerny E, Pazdur R.
    Anticancer Drugs; 2001 Jul 01; 12(6):499-503. PubMed ID: 11459995
    [Abstract] [Full Text] [Related]

  • 8. Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study.
    Lee DJ, Trotti A, Spencer S, Rostock R, Fisher C, von Roemeling R, Harvey E, Groves E.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):811-5. PubMed ID: 9845102
    [Abstract] [Full Text] [Related]

  • 9. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.
    Del Rowe J, Scott C, Werner-Wasik M, Bahary JP, Curran WJ, Urtasun RC, Fisher B.
    J Clin Oncol; 2000 Mar 01; 18(6):1254-9. PubMed ID: 10715295
    [Abstract] [Full Text] [Related]

  • 10. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.
    Rischin D, Peters L, Hicks R, Hughes P, Fisher R, Hart R, Sexton M, D'Costa I, von Roemeling R.
    J Clin Oncol; 2001 Jan 15; 19(2):535-42. PubMed ID: 11208848
    [Abstract] [Full Text] [Related]

  • 11. Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group study.
    Coleman CN, Noll L, Riese N, Buswell L, Howes AE, Loeffler JS, Alexander E, Wen P, Harris JR, Kramer RA.
    Int J Radiat Oncol Biol Phys; 1992 Jan 15; 22(3):577-80. PubMed ID: 1531217
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
    Le QT, McCoy J, Williamson S, Ryu J, Gaspar LE, Edelman MJ, Dakhil SR, Sides SD, Crowley JJ, Gandara DR, Southwest oncology group.
    Clin Cancer Res; 2004 Aug 15; 10(16):5418-24. PubMed ID: 15328179
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.
    Aghajanian C, Brown C, O'flaherty C, Fleischauer A, Curtin J, Roemeling R, Spriggs DR.
    Gynecol Oncol; 1997 Nov 15; 67(2):127-30. PubMed ID: 9367694
    [Abstract] [Full Text] [Related]

  • 14. Tirapazamine: from bench to clinical trials.
    Marcu L, Olver I.
    Curr Clin Pharmacol; 2006 Jan 15; 1(1):71-9. PubMed ID: 18666379
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
    Cohen EE, Rosine D, Haraf DJ, Loh E, Shen L, Lusinchi A, Vokes EE, Bourhis J.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):678-84. PubMed ID: 17293229
    [Abstract] [Full Text] [Related]

  • 17. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
    Shibata T, Shibamoto Y, Sasai K, Oya N, Murata R, Takagi T, Hiraoka M, Takahashi M, Abe M.
    Br J Cancer Suppl; 1996 Jul 01; 27():S61-4. PubMed ID: 8763848
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tirapazamine: a novel agent targeting hypoxic tumor cells.
    Reddy SB, Williamson SK.
    Expert Opin Investig Drugs; 2009 Jan 01; 18(1):77-87. PubMed ID: 19053884
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.